AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy
- 27 August 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 308, 120911
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/17177-6, 2017/24993-0, 2018/17595-0, 2018/19372-9, 2019/23864-7, 2021/11606-3)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (150531/2022-2)
This publication has 39 references indexed in Scilit:
- Epigenetic and genetic features of 24 colon cancer cell linesOncogenesis, 2013
- Tbx2 Controls Lung Growth by Direct Repression of the Cell Cycle Inhibitor Genes Cdkn1a and Cdkn1bPLOS Genetics, 2013
- RET is a potential tumor suppressor gene in colorectal cancerOncogene, 2012
- Chemical genetic discovery of targets and anti-targets for cancer polypharmacologyNature, 2012
- An Update on the Biology of RAS/RAF Mutations in Colorectal CancerCurrent Colorectal Cancer Reports, 2011
- Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalizationOncogene, 2009
- ERK activity facilitates activation of the S-phase DNA damage checkpoint by modulating ATR functionOncogene, 2005
- ERK Activation Mediates Cell Cycle Arrest and Apoptosis after DNA Damage Independently of p53Journal of Biological Chemistry, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983